Filed under: Cancer & Chemo
Multiple myeloma is a cancer of your plasma cells, a type of white blood cell present in your bone marrow. Plasma cells normally make proteins called antibodies to help you fight infections.
In multiple myeloma, a group of abnormal plasma cells (myeloma cells) multiplies, raising the number of plasma cells to a higher than normal level. Since these cells normally make proteins, the level of abnormal proteins in your blood also may go up. Health problems caused by multiple myeloma can affect your bones, immune system, kidneys and red blood cell count.
If you have multiple myeloma but don't have symptoms, your doctors may just monitor your condition. If you're experiencing symptoms, a number of treatments are available to help control multiple myeloma.
©1998-2009 Mayo Foundation for Medical Education and Research (MFMER). Terms of use.
Signs and symptoms of multiple myeloma can vary from person to person. Although the condition may not cause symptoms early in the disease, it's likely that you'll experience one or more of the following as the disease progresses:
If you have a high calcium level in your blood, you may experience signs and symptoms such as:
Other signs and symptoms of multiple myeloma may include:
When to see a doctor
If you're persistently more tired than you used to be, you've lost weight, and you experience bone pain, repeated infections, loss of appetite, excessive thirst and urination, persistent nausea, increased constipation, or weakness or numbness in your legs, your signs and symptoms may indicate multiple myeloma or other serious disease. See your doctor to determine the underlying cause.
©1998-2009 Mayo Foundation for Medical Education and Research (MFMER). Terms of use.
Although the exact cause isn't known, doctors do know that multiple myeloma begins with one abnormal plasma cell in your bone marrow — the soft, blood-producing tissue that fills in the center of most of your bones. This abnormal cell then starts to multiply.
Because abnormal cells don't mature and then die as normal cells do, they accumulate, eventually overwhelming the production of healthy cells. In healthy bone marrow, less than 5 percent of the cells are plasma cells. But in people with multiple myeloma, more than 10 percent of the cells may be plasma cells.
Because myeloma cells may circulate in low numbers in your blood, they can populate bone marrow in other parts of your body, even far from where they began. That's why the disease is called multiple myeloma. Uncontrolled plasma cell growth can damage bones and surrounding tissue. It can also interfere with your immune system's ability to fight infections by inhibiting your body's production of normal antibodies.
Researchers investigating cause
Researchers are studying the DNA of plasma cells to try to understand what changes occur that cause these cells to become cancer cells. Though they haven't yet discovered the cause of these changes, they have found that almost all people with multiple myeloma have genetic abnormalities in their plasma cells that probably contributed to the cancer. For example, many myeloma cells are missing all or part of one chromosome — chromosome 13. Cells with a missing or defective chromosome 13 tend to be more aggressive and harder to treat than are cells with a normal chromosome 13.
A connection with MGUS
Multiple myeloma almost always starts out as a relatively benign condition called monoclonal gammopathy of undetermined significance (MGUS). In the United States, about 3 percent of people over the age of 50 have MGUS. Each year, about 1 percent of people with MGUS develop multiple myeloma or a related cancer. This condition, like multiple myeloma, is marked by the presence of M proteins — produced by abnormal plasma cells — in your blood. However, in MGUS, no damage to the body occurs.
©1998-2009 Mayo Foundation for Medical Education and Research (MFMER). Terms of use.
Multiple myeloma isn't contagious. Most people who develop multiple myeloma have no clearly identifiable risk factors for the disease.
Some factors that may increase your risk of multiple myeloma include:
Other factors that may increase your risk of developing multiple myeloma include exposure to radiation and working in petroleum-related industries.
©1998-2009 Mayo Foundation for Medical Education and Research (MFMER). Terms of use.
Multiple myeloma can result in several complications:
©1998-2009 Mayo Foundation for Medical Education and Research (MFMER). Terms of use.
In many cases, multiple myeloma is discovered as part of routine blood and urine tests during a medical checkup. To increase the odds of catching this and other serious conditions as early as possible, follow the recommended schedule for your age and sex for general physical examinations.
If you have symptoms that are common to multiple myeloma — such as back pain, weakness and fatigue, poor appetite and weight loss, or repeated infections — call your doctor. After your doctor sees you, you may be referred to a specialist in the diagnosis and treatment of cancer (oncologist).
Because appointments can be brief and because there's often a lot of ground to cover, it's a good idea to be well prepared for your appointment. Here's some information to help you get ready and on what to expect from your doctor.
What you can do
Questions to ask your doctor at your initial appointment include:
Questions to consider if your doctor refers you to an oncologist include:
In addition to the questions, don't hesitate to ask questions during your appointment at any time that you don't understand something.
What to expect from your doctor
Your doctor is likely to ask you a number of questions. Thinking about your answers ahead of time can help you make the most of your appointment. A doctor who sees you for possible multiple myeloma may ask:
What you can do in the meantime
While you wait for your appointment, check with your family members to find out if any relatives have been diagnosed with multiple myeloma or with plasma disorders such as MGUS.
©1998-2009 Mayo Foundation for Medical Education and Research (MFMER). Terms of use.
Your doctor may first detect signs of multiple myeloma before you ever have symptoms — through blood and urine tests conducted during a routine physical exam. If you don't yet have symptoms, these lab tests may be repeated every few months so that your doctor can track whether your disease is progressing and determine the best time to start treatment.
Blood and urine tests
A blood test called serum protein electrophoresis separates your blood proteins and can detect the presence of M proteins, called an "M spike," in your blood. Parts of M proteins may also be detected in a test of your urine — when found in urine, they're referred to as Bence Jones proteins.
If your doctor discovers M proteins, you'll likely need additional blood tests to measure blood cell counts and levels of calcium, uric acid and creatinine. Your doctor may also conduct other blood tests to check for beta2-microglobulin — another protein produced by myeloma cells — or to measure the percent of plasma cells in your bone marrow.
Other tests
You may also need other tests. They may include:
Staging and classification
These tests can help confirm whether you have multiple myeloma or another condition. If tests indicate you have multiple myeloma, the results from these tests allow your doctor to classify your disease as stage 1, stage 2 or stage 3. People with stage 3 myeloma are more likely to have one or more signs of advanced disease, including greater numbers of myeloma cells and kidney failure.
©1998-2009 Mayo Foundation for Medical Education and Research (MFMER). Terms of use.
If you have multiple myeloma and aren't experiencing any symptoms, you may not need treatment. However, your doctors will regularly monitor your condition for signs that indicate the disease is progressing. If it is, you may need treatment to help prevent symptoms.
If you're experiencing symptoms, treatment can help relieve pain, control complications of the disease, stabilize your condition and slow the progress of the disease.
Standard treatments for myeloma
Though there's no cure for multiple myeloma, with good treatment results you can usually return to near-normal activity. You may wish to consider approved clinical trials as an option.
Standard treatment options include:
Initial therapy for myeloma
The initial chemotherapy used to treat multiple myeloma depends on whether you're considered a candidate for stem cell transplantation. Factors such as the risk of your disease progressing, your age and your general health play a part in determining whether stem cell transplantation may be right for you.
If you're considered a candidate for stem cell transplantation, your initial therapy will likely exclude melphalan because this drug can have a toxic effect on stem cells, making it impossible to collect enough of them. Your first treatment will typically be lenalidomide or bortezomib combined with low-dose dexamethasone.
Your stem cells will likely be collected after you've undergone three to four months of treatment with these initial agents. Your doctor may recommend undergoing the stem cell transplant soon after your cells are collected or delaying the transplant until after a relapse, if it occurs. Your age and your personal preference are important factors that will help your doctor make a recommendation.
After your stem cell transplantation, you'll likely start a new course of treatment with a drug combination that includes bortezomib and melphalan.
Treatments for relapsed or treatment-resistant multiple myeloma
Most people who are treated for multiple myeloma eventually experience a relapse of the disease. And in some cases, none of the currently available, first line therapies slow the cancer cells from multiplying. If you experience a relapse of multiple myeloma, your doctor may recommend repeating another course of the treatment that initially helped you. Another option is trying one or more of the other treatments typically used as first line therapy, either alone or in combination.
Research on a number of new treatment options is ongoing, and these drugs offer important options for those with multiple myeloma. Talk to your doctor about what clinical trials may be available to you.
Treating complications
Because multiple myeloma can cause a number of complications, you may also need treatment for those specific conditions. For example:
©1998-2009 Mayo Foundation for Medical Education and Research (MFMER). Terms of use.
The following tips may help you keep multiple myeloma under control:
©1998-2009 Mayo Foundation for Medical Education and Research (MFMER). Terms of use.
While no alternative therapies have been specifically approved for the treatment of multiple myeloma, the following approaches have been found useful for cancer-related problems:
Talk with your doctor before trying any of these techniques to make sure they don't pose any risks for you.
©1998-2009 Mayo Foundation for Medical Education and Research (MFMER). Terms of use.
A diagnosis of cancer can be extremely challenging. Remember that no matter what your concerns or prognosis, you're not alone. These strategies and resources may make dealing with cancer easier:
©1998-2009 Mayo Foundation for Medical Education and Research (MFMER). Terms of use.


